Empowered Funds
NNVC icon

Empowered Funds’s NanoViricides NNVC Stock Holding History

Empowered Funds’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$46.1K Buy
+35,438
New +$49.7K ﹤0.01% 2481

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Miller Financial Services
Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.87B AUM 19.94% 1-Year Est. Return

Empowered Funds's NNVC Position: Q3 2026 in Review

Empowered Funds opened a new position in NanoViricides (NNVC) in Q3 2026: 35,438 shares worth $46.1K. The stake represents ﹤0.01% of the portfolio and ranks #2481 among its holdings.

38 funds tracked by Wall St. Rank hold NNVC as of Q3 2026.

  • Empowered Funds held 35,438 shares of NanoViricides worth $46.1K as of Q3 2026.
  • NanoViricides was a new Empowered Funds position in Q3 2026.
  • NanoViricides made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2481 holding.
  • 38 funds tracked by Wall St. Rank held NanoViricides as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.